InVision AG
InVision AG (IVX.DE) Stock Competitors & Peer Comparison
See (IVX.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Application Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IVX.DE | €6.00 | -2.44% | 13.4M | -4.48 | -€1.34 | N/A |
| SAP.DE | €246.65 | +0.82% | 285B | 44.10 | €5.55 | +0.96% |
| FOO.F | €220.25 | +0.96% | 209B | 39.18 | €5.58 | +0.67% |
| FOO.DE | €216.10 | -0.83% | 208.9B | 39.03 | €5.60 | +0.67% |
| ITU.DE | €679.70 | +1.16% | 189.9B | 63.31 | €10.75 | +0.56% |
| 307.F | €107.70 | +5.69% | 141.9B | 100.44 | €1.08 | N/A |
| AUD.DE | €287.35 | +0.26% | 61.9B | 109.26 | €2.63 | N/A |
| CDS.DE | €165.64 | +0.00% | 45.4B | 61.12 | €2.71 | N/A |
| 5ZM.F | €62.28 | -3.40% | 18.1B | 21.35 | €2.91 | N/A |
| FFV.DE | €297.70 | +0.40% | 17.4B | 53.83 | €5.53 | N/A |
Stock Comparison
IVX.DE vs SAP.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SAP.DE has a market cap of 285B. Regarding current trading prices, IVX.DE is priced at €6.00, while SAP.DE trades at €246.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SAP.DE's P/E ratio is 44.10. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SAP.DE's ROE of +0.15%. Regarding short-term risk, IVX.DE is less volatile compared to SAP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check SAP.DE's competition here
IVX.DE vs FOO.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FOO.F has a market cap of 209B. Regarding current trading prices, IVX.DE is priced at €6.00, while FOO.F trades at €220.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FOO.F's P/E ratio is 39.18. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FOO.F's ROE of +0.10%. Regarding short-term risk, IVX.DE is less volatile compared to FOO.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FOO.F's competition here
IVX.DE vs FOO.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FOO.DE has a market cap of 208.9B. Regarding current trading prices, IVX.DE is priced at €6.00, while FOO.DE trades at €216.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FOO.DE's P/E ratio is 39.03. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FOO.DE's ROE of +0.10%. Regarding short-term risk, IVX.DE is less volatile compared to FOO.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FOO.DE's competition here
IVX.DE vs ITU.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ITU.DE has a market cap of 189.9B. Regarding current trading prices, IVX.DE is priced at €6.00, while ITU.DE trades at €679.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ITU.DE's P/E ratio is 63.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ITU.DE's ROE of +0.19%. Regarding short-term risk, IVX.DE and ITU.DE have similar daily volatility (0.00).Check ITU.DE's competition here
IVX.DE vs 307.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 307.F has a market cap of 141.9B. Regarding current trading prices, IVX.DE is priced at €6.00, while 307.F trades at €107.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 307.F's P/E ratio is 100.44. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 307.F's ROE of +0.15%. Regarding short-term risk, IVX.DE is less volatile compared to 307.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 307.F's competition here
IVX.DE vs AUD.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, AUD.DE has a market cap of 61.9B. Regarding current trading prices, IVX.DE is priced at €6.00, while AUD.DE trades at €287.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas AUD.DE's P/E ratio is 109.26. In terms of profitability, IVX.DE's ROE is -0.40%, compared to AUD.DE's ROE of +0.45%. Regarding short-term risk, IVX.DE is less volatile compared to AUD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check AUD.DE's competition here
IVX.DE vs CDS.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CDS.DE has a market cap of 45.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while CDS.DE trades at €165.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CDS.DE's P/E ratio is 61.12. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CDS.DE's ROE of +0.25%. Regarding short-term risk, IVX.DE and CDS.DE have similar daily volatility (0.00).Check CDS.DE's competition here
IVX.DE vs 5ZM.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 5ZM.F has a market cap of 18.1B. Regarding current trading prices, IVX.DE is priced at €6.00, while 5ZM.F trades at €62.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 5ZM.F's P/E ratio is 21.35. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 5ZM.F's ROE of +0.12%. Regarding short-term risk, IVX.DE is less volatile compared to 5ZM.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 5ZM.F's competition here
IVX.DE vs FFV.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FFV.DE has a market cap of 17.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while FFV.DE trades at €297.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FFV.DE's P/E ratio is 53.83. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FFV.DE's ROE of +0.19%. Regarding short-term risk, IVX.DE is less volatile compared to FFV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FFV.DE's competition here
IVX.DE vs E3G1.SG Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, E3G1.SG has a market cap of 15.5B. Regarding current trading prices, IVX.DE is priced at €6.00, while E3G1.SG trades at €77.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas E3G1.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to E3G1.SG's ROE of +0.32%. Regarding short-term risk, IVX.DE is less volatile compared to E3G1.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check E3G1.SG's competition here
IVX.DE vs NEM.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, NEM.DE has a market cap of 15.1B. Regarding current trading prices, IVX.DE is priced at €6.00, while NEM.DE trades at €132.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas NEM.DE's P/E ratio is 80.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to NEM.DE's ROE of +0.21%. Regarding short-term risk, IVX.DE is less volatile compared to NEM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check NEM.DE's competition here
IVX.DE vs CTX.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CTX.DE has a market cap of 13.5B. Regarding current trading prices, IVX.DE is priced at €6.00, while CTX.DE trades at €106.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CTX.DE's P/E ratio is 39.97. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CTX.DE's ROE of +0.93%. Regarding short-term risk, IVX.DE and CTX.DE have similar daily volatility (0.00).Check CTX.DE's competition here
IVX.DE vs US44891N2080.SG Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, US44891N2080.SG has a market cap of 2.7B. Regarding current trading prices, IVX.DE is priced at €6.00, while US44891N2080.SG trades at €29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas US44891N2080.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to US44891N2080.SG's ROE of -0.09%. Regarding short-term risk, IVX.DE is less volatile compared to US44891N2080.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check US44891N2080.SG's competition here
IVX.DE vs AOF.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, AOF.DE has a market cap of 1.8B. Regarding current trading prices, IVX.DE is priced at €6.00, while AOF.DE trades at €116.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas AOF.DE's P/E ratio is 40.56. In terms of profitability, IVX.DE's ROE is -0.40%, compared to AOF.DE's ROE of +0.67%. Regarding short-term risk, IVX.DE is less volatile compared to AOF.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check AOF.DE's competition here
IVX.DE vs TMV.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TMV.DE has a market cap of 1.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while TMV.DE trades at €9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TMV.DE's P/E ratio is 10.89. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TMV.DE's ROE of +1.58%. Regarding short-term risk, IVX.DE is less volatile compared to TMV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TMV.DE's competition here
IVX.DE vs RKET.HM Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, RKET.HM has a market cap of 1.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while RKET.HM trades at €16.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas RKET.HM's P/E ratio is 1.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to RKET.HM's ROE of +0.00%. Regarding short-term risk, IVX.DE and RKET.HM have similar daily volatility (0.00).Check RKET.HM's competition here
IVX.DE vs MUM.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, MUM.DE has a market cap of 855.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while MUM.DE trades at €51.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas MUM.DE's P/E ratio is 29.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to MUM.DE's ROE of +0.31%. Regarding short-term risk, IVX.DE is less volatile compared to MUM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check MUM.DE's competition here
IVX.DE vs M8G.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, M8G.DE has a market cap of 710.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while M8G.DE trades at €3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas M8G.DE's P/E ratio is 27.13. In terms of profitability, IVX.DE's ROE is -0.40%, compared to M8G.DE's ROE of +0.07%. Regarding short-term risk, IVX.DE is less volatile compared to M8G.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check M8G.DE's competition here
IVX.DE vs M8G.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, M8G.F has a market cap of 706.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while M8G.F trades at €3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas M8G.F's P/E ratio is 26.96. In terms of profitability, IVX.DE's ROE is -0.40%, compared to M8G.F's ROE of +0.07%. Regarding short-term risk, IVX.DE is less volatile compared to M8G.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check M8G.F's competition here
IVX.DE vs 0S6.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 0S6.DE has a market cap of 660.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while 0S6.DE trades at €14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 0S6.DE's P/E ratio is -2.17. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 0S6.DE's ROE of -2.38%. Regarding short-term risk, IVX.DE is less volatile compared to 0S6.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 0S6.DE's competition here
IVX.DE vs GKS.HM Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, GKS.HM has a market cap of 647.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while GKS.HM trades at €285.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas GKS.HM's P/E ratio is -123.38. In terms of profitability, IVX.DE's ROE is -0.40%, compared to GKS.HM's ROE of -0.06%. Regarding short-term risk, IVX.DE and GKS.HM have similar daily volatility (0.00).Check GKS.HM's competition here
IVX.DE vs GKS.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, GKS.DE has a market cap of 494.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while GKS.DE trades at €219.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas GKS.DE's P/E ratio is -44.88. In terms of profitability, IVX.DE's ROE is -0.40%, compared to GKS.DE's ROE of -0.06%. Regarding short-term risk, IVX.DE is less volatile compared to GKS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check GKS.DE's competition here
IVX.DE vs PSAN.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, PSAN.DE has a market cap of 436.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while PSAN.DE trades at €27.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas PSAN.DE's P/E ratio is -94.00. In terms of profitability, IVX.DE's ROE is -0.40%, compared to PSAN.DE's ROE of -0.23%. Regarding short-term risk, IVX.DE is less volatile compared to PSAN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check PSAN.DE's competition here
IVX.DE vs IVU.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, IVU.DE has a market cap of 359.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while IVU.DE trades at €21.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas IVU.DE's P/E ratio is 29.71. In terms of profitability, IVX.DE's ROE is -0.40%, compared to IVU.DE's ROE of +0.15%. Regarding short-term risk, IVX.DE is less volatile compared to IVU.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check IVU.DE's competition here
IVX.DE vs DBD.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, DBD.DE has a market cap of 233.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while DBD.DE trades at €2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas DBD.DE's P/E ratio is -0.96. In terms of profitability, IVX.DE's ROE is -0.40%, compared to DBD.DE's ROE of +0.53%. Regarding short-term risk, IVX.DE is less volatile compared to DBD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check DBD.DE's competition here
IVX.DE vs SJJ.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SJJ.DE has a market cap of 177.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while SJJ.DE trades at €18.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SJJ.DE's P/E ratio is 422.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SJJ.DE's ROE of -0.00%. Regarding short-term risk, IVX.DE is less volatile compared to SJJ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check SJJ.DE's competition here
IVX.DE vs FAA.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FAA.DE has a market cap of 175.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while FAA.DE trades at €16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FAA.DE's P/E ratio is 20.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FAA.DE's ROE of +0.28%. Regarding short-term risk, IVX.DE is less volatile compared to FAA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FAA.DE's competition here
IVX.DE vs TPG.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TPG.DE has a market cap of 170.4M. Regarding current trading prices, IVX.DE is priced at €6.00, while TPG.DE trades at €8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TPG.DE's P/E ratio is 4.60. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TPG.DE's ROE of +0.29%. Regarding short-term risk, IVX.DE is less volatile compared to TPG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TPG.DE's competition here
IVX.DE vs MSGL.HM Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, MSGL.HM has a market cap of 149.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while MSGL.HM trades at €3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas MSGL.HM's P/E ratio is 12.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to MSGL.HM's ROE of +0.16%. Regarding short-term risk, IVX.DE and MSGL.HM have similar daily volatility (0.00).Check MSGL.HM's competition here
IVX.DE vs 52D0.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 52D0.F has a market cap of 146.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while 52D0.F trades at €0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 52D0.F's P/E ratio is -11.00. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 52D0.F's ROE of -0.12%. Regarding short-term risk, IVX.DE is less volatile compared to 52D0.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 52D0.F's competition here
IVX.DE vs BSS.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, BSS.F has a market cap of 102.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while BSS.F trades at €22.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas BSS.F's P/E ratio is 55.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to BSS.F's ROE of +0.14%. Regarding short-term risk, IVX.DE is less volatile compared to BSS.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check BSS.F's competition here
IVX.DE vs V3S.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, V3S.DE has a market cap of 98.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while V3S.DE trades at €12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas V3S.DE's P/E ratio is -43.75. In terms of profitability, IVX.DE's ROE is -0.40%, compared to V3S.DE's ROE of -0.12%. Regarding short-term risk, IVX.DE is less volatile compared to V3S.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check V3S.DE's competition here
IVX.DE vs ESY.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ESY.DE has a market cap of 87.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while ESY.DE trades at €13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ESY.DE's P/E ratio is -18.71. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ESY.DE's ROE of -0.07%. Regarding short-term risk, IVX.DE is less volatile compared to ESY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ESY.DE's competition here
IVX.DE vs 27H.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 27H.F has a market cap of 68.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while 27H.F trades at €0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 27H.F's P/E ratio is -3.23. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 27H.F's ROE of -0.45%. Regarding short-term risk, IVX.DE is less volatile compared to 27H.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 27H.F's competition here
IVX.DE vs CSH.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CSH.DE has a market cap of 64.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while CSH.DE trades at €7.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CSH.DE's P/E ratio is -13.54. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CSH.DE's ROE of -0.00%. Regarding short-term risk, IVX.DE is less volatile compared to CSH.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check CSH.DE's competition here
IVX.DE vs TR9.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TR9.DE has a market cap of 33.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while TR9.DE trades at €17.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TR9.DE's P/E ratio is -38.15. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TR9.DE's ROE of -0.27%. Regarding short-term risk, IVX.DE and TR9.DE have similar daily volatility (0.00).Check TR9.DE's competition here
IVX.DE vs TR9.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TR9.F has a market cap of 33.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while TR9.F trades at €18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TR9.F's P/E ratio is -41.09. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TR9.F's ROE of -0.27%. Regarding short-term risk, IVX.DE and TR9.F have similar daily volatility (0.00).Check TR9.F's competition here
IVX.DE vs VRL.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, VRL.DE has a market cap of 28.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while VRL.DE trades at €13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas VRL.DE's P/E ratio is -14.41. In terms of profitability, IVX.DE's ROE is -0.40%, compared to VRL.DE's ROE of -0.88%. Regarding short-term risk, IVX.DE is less volatile compared to VRL.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check VRL.DE's competition here
IVX.DE vs US37892C1062.SG Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, US37892C1062.SG has a market cap of 24.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while US37892C1062.SG trades at €1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas US37892C1062.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to US37892C1062.SG's ROE of -0.47%. Regarding short-term risk, IVX.DE is less volatile compared to US37892C1062.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check US37892C1062.SG's competition here
IVX.DE vs NIIN.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, NIIN.DE has a market cap of 23.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while NIIN.DE trades at €0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas NIIN.DE's P/E ratio is -6.60. In terms of profitability, IVX.DE's ROE is -0.40%, compared to NIIN.DE's ROE of -0.29%. Regarding short-term risk, IVX.DE is less volatile compared to NIIN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check NIIN.DE's competition here
IVX.DE vs ISHA.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ISHA.DE has a market cap of 22.3M. Regarding current trading prices, IVX.DE is priced at €6.00, while ISHA.DE trades at €1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ISHA.DE's P/E ratio is -25.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ISHA.DE's ROE of -0.03%. Regarding short-term risk, IVX.DE is less volatile compared to ISHA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ISHA.DE's competition here
IVX.DE vs 1OJ.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 1OJ.F has a market cap of 21.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while 1OJ.F trades at €0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 1OJ.F's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 1OJ.F's ROE of +0.13%. Regarding short-term risk, IVX.DE and 1OJ.F have similar daily volatility (0.00).Check 1OJ.F's competition here
IVX.DE vs TBX.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TBX.F has a market cap of 18.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while TBX.F trades at €8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TBX.F's P/E ratio is 10.93. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TBX.F's ROE of +0.32%. Regarding short-term risk, IVX.DE and TBX.F have similar daily volatility (0.00).Check TBX.F's competition here
IVX.DE vs TBX0.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TBX0.F has a market cap of 14.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while TBX0.F trades at €7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TBX0.F's P/E ratio is 7.82. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TBX0.F's ROE of +0.38%. Regarding short-term risk, IVX.DE and TBX0.F have similar daily volatility (0.00).Check TBX0.F's competition here
IVX.DE vs BWQ.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, BWQ.DE has a market cap of 14.3M. Regarding current trading prices, IVX.DE is priced at €6.00, while BWQ.DE trades at €3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas BWQ.DE's P/E ratio is 7.69. In terms of profitability, IVX.DE's ROE is -0.40%, compared to BWQ.DE's ROE of +0.07%. Regarding short-term risk, IVX.DE is less volatile compared to BWQ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check BWQ.DE's competition here
IVX.DE vs DTD2.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, DTD2.DE has a market cap of 11.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while DTD2.DE trades at €1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas DTD2.DE's P/E ratio is 6.75. In terms of profitability, IVX.DE's ROE is -0.40%, compared to DTD2.DE's ROE of +0.12%. Regarding short-term risk, IVX.DE is less volatile compared to DTD2.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check DTD2.DE's competition here
IVX.DE vs ABX.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ABX.DE has a market cap of 9.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while ABX.DE trades at €2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ABX.DE's P/E ratio is 5.35. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ABX.DE's ROE of -0.09%. Regarding short-term risk, IVX.DE is less volatile compared to ABX.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ABX.DE's competition here
IVX.DE vs 2LH.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 2LH.F has a market cap of 8.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while 2LH.F trades at €3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 2LH.F's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 2LH.F's ROE of -0.02%. Regarding short-term risk, IVX.DE is less volatile compared to 2LH.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 2LH.F's competition here
IVX.DE vs 8DQ.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 8DQ.F has a market cap of 6.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while 8DQ.F trades at €0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 8DQ.F's P/E ratio is -0.07. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 8DQ.F's ROE of -0.53%. Regarding short-term risk, IVX.DE and 8DQ.F have similar daily volatility (0.00).Check 8DQ.F's competition here
IVX.DE vs CPU2.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CPU2.F has a market cap of 4.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while CPU2.F trades at €0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CPU2.F's P/E ratio is 100.00. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CPU2.F's ROE of +0.02%. Regarding short-term risk, IVX.DE and CPU2.F have similar daily volatility (0.00).Check CPU2.F's competition here
IVX.DE vs JE00B1Z48326.SG Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, JE00B1Z48326.SG has a market cap of 1.4M. Regarding current trading prices, IVX.DE is priced at €6.00, while JE00B1Z48326.SG trades at €0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas JE00B1Z48326.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to JE00B1Z48326.SG's ROE of -0.99%. Regarding short-term risk, IVX.DE is less volatile compared to JE00B1Z48326.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check JE00B1Z48326.SG's competition here
IVX.DE vs PLARTGS00019.SG Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, PLARTGS00019.SG has a market cap of 491.9K. Regarding current trading prices, IVX.DE is priced at €6.00, while PLARTGS00019.SG trades at €0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas PLARTGS00019.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to PLARTGS00019.SG's ROE of -0.51%. Regarding short-term risk, IVX.DE is less volatile compared to PLARTGS00019.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check PLARTGS00019.SG's competition here
IVX.DE vs 9J4.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 9J4.F has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while 9J4.F trades at €0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 9J4.F's P/E ratio is -1.49. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 9J4.F's ROE of -0.37%. Regarding short-term risk, IVX.DE and 9J4.F have similar daily volatility (0.00).Check 9J4.F's competition here
IVX.DE vs 1HD.F Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 1HD.F has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while 1HD.F trades at €0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 1HD.F's P/E ratio is -21.59. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 1HD.F's ROE of N/A. Regarding short-term risk, IVX.DE and 1HD.F have similar daily volatility (0.00).Check 1HD.F's competition here
IVX.DE vs SC2.DE Comparison August 2025
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SC2.DE has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while SC2.DE trades at €50.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SC2.DE's P/E ratio is -168.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SC2.DE's ROE of -0.01%. Regarding short-term risk, IVX.DE and SC2.DE have similar daily volatility (0.00).Check SC2.DE's competition here